• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRAF V600E 突变分析简化了林奇综合征的检测算法。

BRAF V600E mutation analysis simplifies the testing algorithm for Lynch syndrome.

机构信息

Department of Pathology, Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

出版信息

Am J Clin Pathol. 2013 Aug;140(2):177-83. doi: 10.1309/AJCPB9FOVH1HGKFR.

DOI:10.1309/AJCPB9FOVH1HGKFR
PMID:23897252
Abstract

OBJECTIVES

To evaluate our experience of adding reflex BRAF mutation analysis following mismatch repair (MMR) protein staining in the test algorithm for Lynch syndrome (LS), the most common inherited predisposition to colorectal cancer (CRC).

METHODS

Since January 1, 2009, BRAF V600E mutation analysis has been performed at our institution for all newly diagnosed CRCs with absent MLH1 and PMS2 proteins.

RESULTS

Ninety (22%) of 412 patients with CRC had at least 1 MMR absent (65 had MLH1 and PMS2 absent and 25 had other stain(s) absent). BRAF mutation was found in 36 (55%) of 65. Fifty-four (13%) of 412 patients required follow-up after addition of BRAF analysis compared with 90 who would have required follow-up without BRAF analysis.

CONCLUSIONS

The addition of reflex BRAF mutation testing in CRCs with absent MLH1 and PMS2 reduced the number of patient contacts by 40% and simplified the genetic testing for LS, leading to cost and time savings.

摘要

目的

评估我们在林奇综合征(LS)检测算法中增加错配修复(MMR)蛋白染色后进行 BRAF 反射突变分析的经验,LS 是结直肠癌(CRC)最常见的遗传易感性。

方法

自 2009 年 1 月 1 日起,我们机构对所有新诊断的 CRC 中 MLH1 和 PMS2 蛋白缺失的患者进行 BRAF V600E 突变分析。

结果

在 412 例 CRC 患者中,有 90 例(22%)至少有一种 MMR 缺失(65 例 MLH1 和 PMS2 缺失,25 例其他染色缺失)。在 65 例 MLH1 和 PMS2 缺失的患者中,发现 BRAF 突变 36 例(55%)。与不进行 BRAF 分析需要随访 90 例相比,添加 BRAF 分析后需要随访的患者为 54 例(13%)。

结论

在 MLH1 和 PMS2 缺失的 CRC 中增加反射 BRAF 突变检测可将患者接触次数减少 40%,并简化 LS 的基因检测,从而节省成本和时间。

相似文献

1
BRAF V600E mutation analysis simplifies the testing algorithm for Lynch syndrome.BRAF V600E 突变分析简化了林奇综合征的检测算法。
Am J Clin Pathol. 2013 Aug;140(2):177-83. doi: 10.1309/AJCPB9FOVH1HGKFR.
2
BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.用于排除 MSI-H 结直肠癌中林奇综合征的 BRAF V600E 特异性免疫组化。
Int J Cancer. 2013 Oct 1;133(7):1624-30. doi: 10.1002/ijc.28183. Epub 2013 Apr 25.
3
A modified Lynch syndrome screening algorithm in colon cancer: BRAF immunohistochemistry is efficacious and cost beneficial.一种用于结肠癌的改良林奇综合征筛查算法:BRAF免疫组织化学有效且具有成本效益。
Am J Clin Pathol. 2015 Mar;143(3):336-43. doi: 10.1309/AJCP4D7RXOBHLKGJ.
4
Frequency and application of the hot spot BRAF gene mutation (p.V600E) in the diagnostic strategy for Hereditary Nonpolyposis Colorectal Cancer.热点BRAF基因突变(p.V600E)在遗传性非息肉病性结直肠癌诊断策略中的频率及应用
Cancer Detect Prev. 2007;31(3):254-6. doi: 10.1016/j.cdp.2007.04.001. Epub 2007 Jun 12.
5
A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening.一项针对林奇综合征筛查的BRAF突变分析的前瞻性、多中心、基于人群的研究。
Clin Gastroenterol Hepatol. 2008 Feb;6(2):206-14. doi: 10.1016/j.cgh.2007.10.011. Epub 2007 Dec 21.
6
Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysis.通过选择性错配修复蛋白免疫组织化学检测筛查林奇综合征并转诊至临床遗传学:一项审计与成本分析
J Clin Pathol. 2015 Dec;68(12):1036-9. doi: 10.1136/jclinpath-2015-203083. Epub 2015 Jul 22.
7
Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.肿瘤测序评估替代林奇综合征筛查和当前结直肠癌患者的分子检测。
JAMA Oncol. 2018 Jun 1;4(6):806-813. doi: 10.1001/jamaoncol.2018.0104.
8
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.BRAF筛查作为一种简化遗传性非息肉病性结直肠癌(HNPCC)基因检测的低成本有效策略。
J Med Genet. 2004 Sep;41(9):664-8. doi: 10.1136/jmg.2004.020651.
9
Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.通过对高频微卫星不稳定的结直肠癌中MLH1的特定3'启动子甲基化或BRAF突变进行高效分子筛查林奇综合征
Oncol Rep. 2009 Jun;21(6):1577-83. doi: 10.3892/or_00000390.
10
Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.台湾林奇综合征不同基因检测策略的成本效益分析
PLoS One. 2016 Aug 2;11(8):e0160599. doi: 10.1371/journal.pone.0160599. eCollection 2016.

引用本文的文献

1
Development and evaluation of INTGRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndrome.INTGRATE的开发与评估:一个基于肿瘤特征谱信息全面评估种系变异在林奇综合征中作用的平台
Front Oncol. 2024 Jan 24;13:1284690. doi: 10.3389/fonc.2023.1284690. eCollection 2023.
2
A Case of Lynch Syndrome-Associated Colorectal Adenocarcinoma in a 19-Year-Old Female Patient.一名19岁女性患者的林奇综合征相关结直肠癌病例
Cureus. 2023 Nov 13;15(11):e48740. doi: 10.7759/cureus.48740. eCollection 2023 Nov.
3
Evaluating utility and feasibility of mismatch repair testing of colorectal cancer patients in a low-middle-income country.
评估中低收入国家结直肠癌患者错配修复检测的效用和可行性。
Sci Rep. 2022 Jun 29;12(1):10998. doi: 10.1038/s41598-022-14644-6.
4
Diagnostics of Mutations in MMR/ Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome.错配修复(MMR)基因中的突变诊断及其在林奇综合征患者治疗和护理中的作用
Diagnostics (Basel). 2020 Oct 5;10(10):786. doi: 10.3390/diagnostics10100786.
5
Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.错配修复系统相关基因及基因组在林奇综合征中的作用。
Int J Clin Oncol. 2019 Sep;24(9):999-1011. doi: 10.1007/s10147-019-01494-y. Epub 2019 Jul 4.
6
Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.使用抗BRAF V600E(VE1)小鼠单克隆抗体进行免疫组织化学检测是检测结肠癌中BRAF V600E突变的一种灵敏方法:对120例有无KRAS突变的病例进行评估并文献综述
Pathol Oncol Res. 2019 Jan;25(1):349-359. doi: 10.1007/s12253-017-0344-x. Epub 2017 Nov 10.
7
Molecular genetics of microsatellite-unstable colorectal cancer for pathologists.面向病理学家的微卫星不稳定型结直肠癌分子遗传学
Diagn Pathol. 2017 Mar 4;12(1):24. doi: 10.1186/s13000-017-0613-8.
8
Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.在II期结直肠癌不断演变的背景下肿瘤学家对基因和分子检测的选择
J Oncol Pract. 2016 Mar;12(3):e308-19, 259-60. doi: 10.1200/JOP.2015.007062.
9
Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?应用公共卫生筛查标准:对于患有结直肠癌的成年人,新生儿普遍筛查与林奇综合征的普遍肿瘤筛查相比如何?
J Genet Couns. 2015 Jun;24(3):409-20. doi: 10.1007/s10897-014-9769-5. Epub 2014 Oct 18.
10
VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma.VE1 免疫组化检测准确地检测结直肠癌中的 BRAF V600E 突变,可用于检测低分化结直肠锯齿状腺癌。
Virchows Arch. 2014 Jun;464(6):637-43. doi: 10.1007/s00428-014-1555-0. Epub 2014 Apr 11.